Predictors for microinvasion of small hepatocellular carcinoma ≤2 cm

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 2027-2034

  Yamashita, Yo Ichi ^a,b   Tsuijita, Eiji ^a,b   Takeishi, Kazuki ^a,b   Fujiwara, Megumu ^a   Kira, Shinsuke ^a   Mori, Masaki ^a   Aishima, Shinichi ^b   Taketomi, Akinobu ^b   Shirabe, Ken ^b   Ishida, Terutoshi ^a,b   Maehara, Yoshihiko ^b  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DECARBOXYPROTHROMBIN;

ADULT; AGED; CANCER INVASION; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATIC VEIN; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROINVASION; OVERALL SURVIVAL; PORTAL VEIN; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865116374     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2195-0     Document Type: Review

References (41)

1. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086-92. (Pubitemid 41341758)
2. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22:172-8.
3. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277-87.
4. Jonas S, Bechstein WO, Steinmüller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepa-tology. 2001;33:1080-6. (Pubitemid 32378206)
5. Taketomi A, Sanefuji K, Soejima Y, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepa-tocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531-7.
6. Choi GH, Han DH, Kim DH, et al. Outcome after curative resection for a huge (or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg. 2009;198:693-701.
7. Nagano Y, Tanaka K, Togo S, et al. Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg. 2005;29:66-71. (Pubitemid 40576491)
8. Theise ND, Marcelin K, Goldfischer M, Hytiroglou P, Ferrell L, Thung SN. Low proliferative activity in macroregenerative nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver. 1996;16:134-9. (Pubitemid 26129092)
9. Yamashita Y, Taketomi A, Itoh S, et al. Longterm favorable results of limited hepatic resections for patients with hepatocel-lular carcinoma: 20 years of experience. J Am Coll Surg. 2007; 205:19-26. (Pubitemid 47016949)
10. Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155-8. (Pubitemid 17022541)
11. Lanois B. The intrahepatic Glissonian approach to liver resection. In: Blumgart LH, Fong Y. Surgery of the liver and biliary tract. 3rd ed. Vol. 2. London: WB Saunders, 2000. p. 1698-703.
12. Shimada M, Hashizume M, Maehara S, et al. Laparoscopic hepatectomy for hepatocellular carcinoma. Surg Endosc. 2001; 15:541-4. (Pubitemid 32500116)
13. Yamashita Y, Shimada M, Hamatsu T, et al. Effects of preop-erative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg. 2001;136: 328-33. (Pubitemid 32204971)
14. Yamashita Y, Hamatsu T, Rikimaru T, et al. Bile leakage after hepatic resection. Ann Surg. 2001;233:45-50. (Pubitemid 32042774)
15. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, 5th edn., rev. edn. Tokyo: Kanehara, 2009.
16. Ueno S, Kubo F, Sakoda M, et al. Efficacy of anatomic resection vs. nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg. 2008;15:493-500.
17. Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996; 131:71-6. (Pubitemid 26015411)
18. Shimada M, Takenaka K, Taguchi K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 1998;227:80-5. (Pubitemid 28071341)
19. Takayama T, Makuuchi M, Kojiro M, et al. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol. 2008;15:972-8.
20. Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocel-lular carcinoma as an entity with a high rate of surgical cure. Hepatology. 1998;28:1241-6. (Pubitemid 28493833)
21. Livraghi T, Meloni F, Morabito A, Vettori C. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl. 2004;10:S98-106.
22. Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg. 2004;240:451-9.
23. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2008;47:82-9. (Pubitemid 351171044)
24. Chen MS, Li JQ, Zheng Y, Guo RP, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321-8. (Pubitemid 43327762)
25. Zhou Y, Zhao Y, Li B, et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol. 2010;10:78.
26. Makuuchi M, Kokudo N, Arii S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37-51. (Pubitemid 350182575)
27. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127:603-8.
28. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clini-copathological factors. Ann Surg Oncol. 2008;15:1375-82.
29. Jonas S, Bechstein WO, Steinmüller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepa-tology. 2001;33:1080-6. (Pubitemid 32378206)
30. Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preop-erative treatments. Cancer. 1996;77:2022-31. (Pubitemid 26142044)
31. Eguchi S, Takatsuki M, Hidaka M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg. 2010;34:1034-8.
32. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal vein invasion and intrahepatic micrometas-tasis in small hepatocellular carcinoma by gross type. Hepatol Res. 2003;26:142-7. (Pubitemid 36927185)
33. Shirabe K, Itoh S, Yoshizumi T, et al. The predictors of micro-vascular invasion in candidates for liver transplantation with hepatocellular carcinoma, with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007; 95:235-40.
34. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2010;102:462-8.
35. Shirabe K, Kajiyama K, Abe T, et al. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio. J Gastroenterol Hepatol. 2009;24:1431-6.
36. Miyata R, Tanimoto A, Wakabayashi G, et al. Accuracy of pre-operative prediction of microinvasion of portal vein in hepatocellular carcinoma using superparamagnetic iron oxide-enhanced magnetic resonance imaging and computed tomography during hepatic angiography. J Gastroenterol. 2006;41:987-95. (Pubitemid 44741412)
37. Koike Y, Shiratori Y, Sato S, et al. Des-gamma-carboxy pro-thrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer. 2001;91:561-9. (Pubitemid 32105702)
38. Shirabe K, Aishima S, Taketomi A, et al. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation. Br J Surg. 2011;98:261-7.
39. Hui AM, Takayama T, Sano K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol. 2000;33:975-9.
40. Ueno S, Kubo F, Sakoda M, et al. Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg. 2008;15:493-500.
41. Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245:36-43. (Pubitemid 46035433)